5th conference on The Global Harmonization Initiative
28. in 29. september 2022, Amsterdam, The Netherlands
The topics of the next conference have been fixed:
•Fed vs fasted studies for immediate release dosage forms: relevance of excipients,disintegration/dissolution specificities, drug substance properties and physiologicalGI conditions – new findings shall help achieve harmonisation
•Statistical considerations for BE assessment: replicate design for BE of Highly VariableDrugs, two-stage design and PK modelling as supportive tools for BE assessment
•Topical products: Scientifically-based approaches for a waiver of clinical endpointtrials
•Narrow therapeutic index drugs: study design and acceptance criteria
The Global Bioequivalence Harmonisation Initiative is intended to support the process of global harmonization via scientific discussion among international stakeholders. Therefore, a series of international conferences was founded by EUFEPS in collaboration with AAPS supported from the beginning by the European Medicines Agency (EMA) as well as the U.S. Food and Drug Administration (FDA).
Regulators and speakers from other countries/regions, e.g., Canada, Chile, China, India, Japan, Jordan, Mexico, and Brazil, will be invited to the discussions. Such global participation presents an ideal platform for scientists from regulatory agencies, pharmaceutical industry and academia to exchange their experience and scientific viewpoints: scientific consensus should constitute the most appropriate basis for harmonization.
The Organising Committee of the 5th GBHI Workshop is now presenting the topics, date and venue of the next conference. After the 4th conference in Washington in 2019, now
Amsterdam has again been selected as the location. The conference is planned as a hybrid conference in which some participants can attend at the venue – depending on the severity of the Covid-19 pandemic in Europe and worldwide – while offering virtual access to all those who cannot manage to travel to Amsterdam.
EUFEPS SEMINAR: “From The Finite Absorption Time (FAT) Concept To The Physiologically Based Finite Time Pharmacokinetic (PBFTPK) Models”.
The seminar will take place on July 6, 2022 from 2 pm – 6 pm CEST as a virtual meeting.
|2.00 pm||Panos Macheras, Department of Pharmacy, National & Kapodistrian Univeristy of Athens, Greece||The rise of finite absorption time (FAT) concept and the physiologically based finite time pharmacokinetic (PBFTPK) models|
|2.45 pm||Thanos Tsekouras, Department of Chemistry, National & Kapodistrian Univeristy of Athens, Greece||Analysis of pharmacokinetic data using the PBFTPK software|
|3.45 pm||Panos Macheras, Department of Pharmacy, National & Kapodistrian Univeristy of Athens, Greece||Implications of FAT on Bioavailability, Bioequivalence, Biowaivers and IVIVC|
|4.30 pm||Filippos Kesisoglou, Di Wu, Merck & Co., Inc., Rahway, NJ, USA||PBPK models under the prism of FAT concept|
Please register here: https://civi.eufeps.org/index.php?option=com_civicrm&task=civicrm/event/register&reset=1&id=4
A registration with the following fees is needed for this event:
|Academia / Government||100.00|